MDLN - Company ID 0002046386
The table below shows Medline Inc.'s income statement line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Revenue | $28.43B | $25.51B | $23.23B |
| Cost of revenue | $20.91B | $18.53B | $17.35B |
| Gross profit | $7.52B | $6.98B | $5.88B |
| R&D | $80.00M | $67.00M | $60.00M |
| SG&A | $4.52B | $4.11B | $3.87B |
| Operating income | $2.21B | $2.15B | $1.25B |
| Income tax | $91.00M | $46.00M | $30.00M |
| Net income |
Medline Inc. reported annual revenue of $28.43B for fiscal year 2025. That is up 11.5% from $25.51B in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.16T |
| - |
| - |
| EPS (diluted) | -$0.01 | - | - |